A detailed history of Td Asset Management Inc transactions in Alector, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 111,738 shares of ALEC stock, worth $214,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,738
Previous 111,738 -0.0%
Holding current value
$214,536
Previous $507,000 2.76%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$3.77 - $8.39 $27,898 - $62,086
-7,400 Reduced 6.21%
111,738 $891,000
Q3 2023

Oct 27, 2023

BUY
$5.2 - $8.77 $560,918 - $946,011
107,869 Added 957.22%
119,138 $772,000
Q1 2023

May 10, 2023

SELL
$5.85 - $9.84 $126,944 - $213,528
-21,700 Reduced 65.82%
11,269 $69,000
Q3 2022

Nov 07, 2022

SELL
$8.19 - $13.2 $56,511 - $91,080
-6,900 Reduced 17.31%
32,969 $312,000
Q2 2022

Aug 04, 2022

SELL
$7.65 - $14.24 $152,908 - $284,629
-19,988 Reduced 33.39%
39,869 $405,000
Q2 2021

Aug 11, 2021

SELL
$15.5 - $22.48 $68,200 - $98,912
-4,400 Reduced 6.85%
59,857 $1.44 Million
Q4 2020

Feb 16, 2021

BUY
$9.4 - $16.7 $234,060 - $415,830
24,900 Added 63.27%
64,257 $972,000
Q2 2020

Aug 13, 2020

BUY
$21.87 - $33.11 $316,655 - $479,399
14,479 Added 58.2%
39,357 $962,000
Q1 2020

May 15, 2020

BUY
$16.25 - $35.28 $404,267 - $877,695
24,878 New
24,878 $600,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.